CoChat

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12‐month data from the OpT2mise randomized trial

Open access
Aronson, R., Reznik, Y., Conget, I., Castañeda, J. A., Runzis, S., Lee, S. W., Cohen, O., for the OpT2mise Study Group · 2016 · Diabetes, Obesity and Metabolism
Cited by 65

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aims: To compare insulin pump therapy and multiple daily injections ( MDI ) in patients with type 2 diabetes receiving basal and prandial insulin analogues. Methods: After a 2‐month dose‐optimization period, 331 patients with glycated haemoglobin ( HbA1c ) levels ≥8.0% and ≤12% were randomized to pump therapy or continued MDI for 6 months [randomization phase ( RP )]. The MDI group was subsequently switched to pump therapy during a 6‐month continuation phase ( CP ). The primary endpoint was the between‐group difference in change in mean HbA1c from baseline to the end of the RP . Results: The mean HbA1c at baseline was 9% in both groups. At the end of the RP , the reduction in HbA1c was significantly greater with pump therapy than with MDI (−1.1 ± 1.2% vs −0.4 ± 1.1%; p < 0.001). The pump therapy group maintained this improvement to 12 months while the MDI group, which was switched to pump therapy, showed a 0.8% reduction: the final HbA1c level was identical in both arms. In the RP , total daily insulin dose ( TDD ) was 20.4% lower with pump therapy than with MDI and remained stable in the CP . The MDI –pump group showed a 19% decline in TDD , such that by 12 months TDD was equivalent in both groups. There were no differences in weight gain or ketoacidosis between groups. In the CP , one patient in each group experienced severe hypoglycaemia. Conclusions: Pump therapy has a sustained durable effect on glycaemic control in uncontrolled type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12642

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 65

Metadata

Authors
Aronson, R., Reznik, Y., Conget, I., Castañeda, J. A., Runzis, S., Lee, S. W., Cohen, O., & for the OpT2mise Study Group
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2016-03-22
Volume
18
Issue
5
Pages
500-507
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2267584932
Cited by
65
References
4
FWCI
10.68
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12‐month data from the OpT2mise randomized trial. https://app.cochat.ai/papers/10.1111/dom.12642
The paper
Aronson, R., Reznik, Y., Conget, I., Castañeda, J. A., Runzis, S., Lee, S. W., Cohen, O., & for the OpT2mise Study Group. (2016). Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12‐month data from the OpT2mise randomized trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12642

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.